Australia TGA ARTG record

NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation

Australia TGA ARTG Registered Device · Device Technologies Australia Pty Ltd · Numed Canada Inc · Class III · Started December 15, 2008

Good Name: Device Technologies Australia Pty Ltd - NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 15, 2008
Effective Date: December 15, 2008

Sponsor

Name: Device Technologies Australia Pty Ltd

Manufacturer

Name: Numed Canada Inc
Country: Canada
Address: 45 Second Street, West Cornwall, Ontario, K6J 1G3

Intended purpose

A flexible, balloon-tipped catheter recomended for use in Percutaneous Transluminal Valvuloplasty (PTV) for mitral and aortic position and centered angioplasty applications.

About this record

Access comprehensive regulatory information for NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Device Technologies Australia Pty Ltd, manufactured by Numed Canada Inc in Canada. The device registration started on December 15, 2008.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.